Here, we describe the correlation between p16 IHC expression and CDKN2A heterozygous and homozygous deletion assessed by FISH in a cohort of low- and high-grade diffuse pediatric- and adult-type gliomas, as well as in circumscribed gliomas. The gene discussed is CDKN2A; the disease is central nervous system cancer.